Literature DB >> 24900657

Interrogation of the Active Sites of Protein Arginine Deiminases (PAD1, -2, and -4) Using Designer Probes.

Angelica M Bello1, Ewa Wasilewski2, Lianhu Wei1, Mario A Moscarello3, Lakshmi P Kotra1.   

Abstract

Protein arginine deiminases (PADs) are involved in a number of cellular pathways, and they catalyze the transformation of peptidyl arginine residue into a citrulline as part of post-translational modifications. To understand ligand preferences, a group of probe molecules were investigated against PAD1, PAD2, and PAD4. These probe molecules carried a well-known covalent modifier of the catalytic cysteine residue, 2-chloroacetamidine moiety, which was tethered to an α-amino acid via a carbon linker. The chain length for the linker varied from 0 to 4. Time-dependent assays indicated that 2-chloroacetamidine (2CA) with no linker inhibited all PAD enzymes with a similar trend in the second-order rate constants, although with poor affinity. Among the other three probe molecules, compound 3 with a three-carbon linker exhibited the best second-order rate constants for optimal ligand reactivity with the binding site. These analyses provide insights into the relative patterns of covalent inactivation of PAD isozymes and the design of novel inhibitors targeting PAD enzymes as potential therapeutic targets.

Entities:  

Keywords:  PAD; chemical probes; inhibitor design; protein arginine deiminase

Year:  2013        PMID: 24900657      PMCID: PMC4027443          DOI: 10.1021/ml300377d

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  20 in total

1.  Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.

Authors:  Justin E Jones; Jessica L Slack; Pengfei Fang; Xuesen Zhang; Venkataraman Subramanian; Corey P Causey; Scott A Coonrod; Min Guo; Paul R Thompson
Journal:  ACS Chem Biol       Date:  2011-10-21       Impact factor: 5.100

2.  A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation.

Authors:  Yuan Luo; Bryan Knuckley; Young-Ho Lee; Michael R Stallcup; Paul R Thompson
Journal:  J Am Chem Soc       Date:  2006-02-01       Impact factor: 15.419

3.  Myelin in multiple sclerosis is developmentally immature.

Authors:  M A Moscarello; D D Wood; C Ackerley; C Boulias
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

4.  The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.

Authors:  Corey P Causey; Justin E Jones; Jessica L Slack; Daisuke Kamei; Larry E Jones; Venkataraman Subramanian; Bryan Knuckley; Pedram Ebrahimi; Alexander A Chumanevich; Yuan Luo; Hiroshi Hashimoto; Mamoru Sato; Lorne J Hofseth; Paul R Thompson
Journal:  J Med Chem       Date:  2011-09-16       Impact factor: 7.446

5.  Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity.

Authors:  Yuji Wang; Pingxin Li; Shu Wang; Jing Hu; Xiangyun Amy Chen; Jianhui Wu; Megan Fisher; Kira Oshaben; Na Zhao; Ying Gu; Dong Wang; Gong Chen; Yanming Wang
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

6.  Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.

Authors:  Bryan Knuckley; Corey P Causey; Justin E Jones; Monica Bhatia; Christina J Dreyton; Tanesha C Osborne; Hidenari Takahara; Paul R Thompson
Journal:  Biochemistry       Date:  2010-06-15       Impact factor: 3.162

7.  Inactivation of two diverse enzymes in the amidinotransferase superfamily by 2-chloroacetamidine: dimethylargininase and peptidylarginine deiminase.

Authors:  Everett M Stone; Terezie H Schaller; Helena Bianchi; Maria D Person; Walter Fast
Journal:  Biochemistry       Date:  2005-10-25       Impact factor: 3.162

8.  Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease.

Authors:  Byungki Jang; Jae-Kwang Jin; Yong-Chul Jeon; Han Jeong Cho; Akihito Ishigami; Kyung-Chan Choi; Richard I Carp; Naoki Maruyama; Yong-Sun Kim; Eun-Kyoung Choi
Journal:  Acta Neuropathol       Date:  2009-12-16       Impact factor: 17.088

9.  Accumulation of citrullinated proteins by up-regulated peptidylarginine deiminase 2 in brains of scrapie-infected mice: a possible role in pathogenesis.

Authors:  Byungki Jang; Eunah Kim; Jin-Kyu Choi; Jae-Kwang Jin; Jae-Il Kim; Akihito Ishigami; Naoki Maruyama; Richard I Carp; Yong-Sun Kim; Eun-Kyoung Choi
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

10.  Active site cysteine is protonated in the PAD4 Michaelis complex: evidence from Born-Oppenheimer ab initio QM/MM molecular dynamics simulations.

Authors:  Zhihong Ke; Yanzi Zhou; Po Hu; Shenglong Wang; Daiqian Xie; Yingkai Zhang
Journal:  J Phys Chem B       Date:  2009-09-24       Impact factor: 2.991

View more
  2 in total

1.  Molecular Mechanism of Protein Arginine Deiminase 2: A Study Involving Multiple Microsecond Long Molecular Dynamics Simulations.

Authors:  Erdem Cicek; Gerald Monard; Fethiye Aylin Sungur
Journal:  Biochemistry       Date:  2022-06-23       Impact factor: 3.321

2.  Protein Arginine Methylation and Citrullination in Epigenetic Regulation.

Authors:  Jakob Fuhrmann; Paul R Thompson
Journal:  ACS Chem Biol       Date:  2015-12-31       Impact factor: 5.100

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.